Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of enriched garlic extract in patients with COVID-19
IRCT20201111049347N1Phase 3Completed
- Sponsor
- Samisaz Pharmaceutical
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of garlic extract in coronavirus disease 2019 (COVID-19), sponsored by Samisaz Pharmaceutical. Started Apr 2021; status: completed.
02
Drugs
garlic extract
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20201111049347N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201111049347N1.